Low-level Environmental Exposure to Lead and Progressive Chronic Kidney Diseases

American Journal of Medicine

Volumn 119, Issue 8, 2006, Pages

  Lin, Ja Liang ^a   Lin Tan, Dan Tzu ^a   Li, Yi Jung ^a   Chen, Kuan Hsing ^a   Huang, Yen Lin ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Low level environmental lead exposure; Nondiabetic chronic kidney diseases; Progressive renal insufficiency; Repeated lead chelation therapy

Indexed keywords

EDETIC ACID; LEAD;

ADULT; AGED; ARTICLE; CHELATION; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE COURSE; DISEASE SEVERITY; ENVIRONMENTAL EXPOSURE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; CHELATION THERAPY; EDETIC ACID; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; LEAD; LEAD POISONING; MALE; MIDDLE AGED;

EID: 33746635557     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2006.01.005     Document Type: Article

References (29)

1. Henderson D.A. The etiology of chronic nephritis in Queensland. Med J Aust 1 (1958) 377-386
2. Wedeen R.P., Maesaka J.K., Weiner B., and Mallick D.K. Occupational lead nephropathy. Am J Med 59 (1975) 630-641
3. Wedeen R.P., Mallick D.K., and Batuman V. Detection and treatment of occupational lead nephropathy. Arch Intern Med 139 (1979) 52-57
4. Nuyts G.D., Daelemans R.A., Jorens PhG., et al. Does lead play a role in the development of chronic renal disease?. Nephrol Dial Transpl 6 (1991) 307-315
5. Staessen J.A., Lauwerys R.R., Buchet J.P., et al. The Cadmibel Study Group. impairment of renal function with increasing blood lead concentrations in the general population. N Engl J Med 327 (1992) 151-156
6. Payton M., Hu H., Sparrow D., and Weiss S.T. Low level lead exposure and renal function in the Normative Aging Study. Am J Epidemiol 140 (1994) 821-829
7. Kim R., Rotnitzky A., Sparrow D., et al. A longitudinal study of low-level lead exposure and impairment of renal function. The Normative Aging Study. JAMA 275 (1996) 1177-1181
8. Pollock C.A., and Ibels L.S. Lead nephropathy-a preventable cause of renal failure. Int J Artif Organs 11 (1988) 75-78
9. Lin J.L., Ho H.H., and Yu C.C. Chelation therapy for paients with elevated body lead burden and progressive renal insufficiency-A randomized, clinical trial. Ann Intern Med 130 (1999) 7-13
10. Lin J.L., Tan D.T., Hsu K.H., and Yu C.C. Environmental lead exposure and progressive renal insufficiency. Arch Intern Med 161 (2001) 264-271
11. Lin J.L., and Lim P.S. Does lead play a role in the development of renal insufficiency in some patients with essential hypertension?. J Hum Hypertens 8 (1994) 495-500
12. Lin J.L., and Huang P.T. Body lead stores and urate excretion in men with chronic renal disease. J Rheumatol 21 (1994) 705-709
13. Lin J.L., and Lim P.S. Disappearance of immune deposits with EDTA chelation therapy in a case of Ig A nephropathy. Am J Nephrol 12 (1992) 457-460
14. Lin J.L., Yeh K.H., Chen W.Y., et al. Urinary N-acetyl-glucosamindase excretion and environmental lead exposure. Am J Nephrol 13 (1993) 442-447
15. Lin J.L., Lin-Tan D.T., Hsu K.H., and Yu C.C. Environmental lead exposure and progression of chronic renal diseases in patients without diabetes. N Engl J Med 348 (2003) 277-286
16. Pirkle J.L., Brody D.J., Gunter E.W., et al. The decline in blood lead levels in the United States. The National Health and Nutrition Examination Surveys (NHANES). JAMA 272 (1994) 184-191
17. Lin J.L., Yu C.C., Lin-Tan D.T., and Ho H.H. Lead chelation therapy and urate excretion in patients with chronic renal insufficiency and gout. Kidney Int 60 (2001) 266-271
18. Isaksson B. Urinary nitrogen output as a validity test in dietary surveys. Am J Clin Nutr 33 (1980) 4-5
19. Behringer D., Craswell P., Mohl C., et al. Urinary lead excretion in uremia patients. Nephron 42 (1986) 323-329
20. Levey A.S., Bosch J.P., Lewis J.B., et al. A more accurate method to estimate glomerular filtration rate from serum creatinine. a new prediction equation. Ann Intern Med 130 (1999) 461-470
21. Hunsicker L.G., Adler S., and Caggiula A. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney Int 51 (1997) 1908-1919
22. Marsden P.A. Increased body lead burden-cause or consequence of chronic renal insufficiency?. N Engl J Med 348 (2004) 345-347
23. Emmerson B.T. Lead stores in patients with renal insufficiency. Nephron 58 (1991) 233-234
24. Campbell B.C., Elliott H.L., and Meredith P.A. Lead exposure and renal failure. does renal insufficiency influence lead kinetics?. Toxicol Lett 9 (1981) 121-124
25. Batuman V., Wedeen R.P., Bogden J.D., et al. Reducing bone lead content by chelation treatment in chronic lead poisoning. an in vivo X-ray fluorescence and bone biopsy study. Environ Res 48 (1989) 70-75
26. Van de Vyver F.L., D'Haese P.C., Visser W.J., et al. Bone lead in dialysis patients. Kidney Int 33 (1988) 601-607
27. Vaziri N.D., Liang K., and Ding Y. Increased nitric oxide inactivation by reactive oxygen species in lead-induced hypertension. Kidney Int 56 (1999) 1492-1498
28. Ding Y., Vaziri N.D., and Gonick H.C. Leadinduced hypertension. II. Response to sequential infusions of L-arginine, superoxide dismutase, and nitroprusside. Environ Res 76 (1998) 107-113
29. Khalil-Manesh F., Gonick H.C., Cohen A., et al. Experimental model of lead nephropathy: II. Effect of removal from lead exposure and chelation treatment with dimercaptosuccinic acid (DMSA). Environ Res 58 (1992) 35-54